Health Care & Life Sciences » Pharmaceuticals | CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
86.59 M
Public Float
49.44 M
CASI Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.35
Market Cap
$292.89 M
Shares Outstanding
95.72 M
Public Float
41.25 M

Profile

Address
9620 Medical Center Drive
Rockville Maryland 20850
United States
Employees -
Website http://www.casipharmaceuticals.com
Updated 07/08/2019
CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market. The firm develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

Financials

View All

Wei-Wu He
Executive Chairman
Ken Keyong Ren
Chief Executive Officer & Director